Current and Emerging Indications for Implantable Cardiac Monitors

Franco Giada, M.D.; Emanuele Bertaglia, M.D; Bernhard Reimers, M.D.; Donatella Noventa, M.D.; Antonio Raviele, M.D.


Pacing Clin Electrophysiol. 2012;35(9):1169-1178. 

In This Article

Final Remarks

In current clinical practice, ICMs are used to evaluate unexplained syncope and palpitations. Furthermore, they can also be used to evaluate difficult cases of epilepsy or unexplained falls, though indications for their application in this area are less clearly defined.

ICMs could be proposed in the near future for the long-term evaluation of the total (symptomatic and asymptomatic) arrhythmic burden in patients at risk of cardiac arrhythmic events. However, the assessment of asymptomatic arrhythmias depends on the ability of ICMs to detect arrhythmic episodes reliably and accurately, and it may vary according to the device used, and the specific arrhythmia. Thus, each device should provide validation data for automatic arrhythmia detection in the various clinical settings. Finally, we still need to wait for the results of ongoing studies regarding the clinical utility of evaluating total arrhythmic burden, in order to determine whether the information obtained from the new-generation ICMs can really help to change the patient's clinical outcome.